Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
The clinical value of amphetamine-type drugs should be reassessed in view of the steady accumulation of evidence that these drugs are not as safe as they were once thought to be, a British physician told the AMA Convention. In the last five years a number of reports have been published giving details of cases of habituation or addiction to these drugs, said Philip H. Connell, MD, the Bethlem Royal and the Maudsley Hospital, London. "It seems clear, therefore, that these drugs, which are prescribed so widely, are not as safe as had been previously suggested, and that a new look into their real value in clinical medicine is needed in order that the prescribing of these drugs can be evaluated in relation to their dangers," Connell said. "The responsibility of the family doctor is a very real one," he added, "and it is a pity that there have been so
JAMA – American Medical Association
Published: Jul 5, 1965
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.